AI Buyer Insights:

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

List of Model N Medicaid Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Janssen United States Life Sciences 9000 $34.0B United States Model N Model N Medicaid Governance, Risk and Compliance 2005 n/a
In 2005, Janssen United States implemented Model N Medicaid to manage Medicaid claims calculations, validations, payment approvals and to generate required ROSI/PQAS reports supporting federal and state rebate compliance. The deployment positioned Model N Medicaid within the Governance, Risk and Compliance category to support finance and regulatory business functions responsible for government rebate submissions and filings. The implementation centered on the Model N Medicaid Claims Processing application, with configured modules for claims calculations, automated validation rules, payment approval workflows and integrated reporting for ROSI and PQAS outputs. Automation of validation logic and embedded reporting workflows enabled a single application to perform calculation, exception detection and report generation tasks typical of Medicaid rebate management. Operational scope covered finance and regulatory teams responsible for Medicaid rebate compliance, including preparation of audit-ready government filings for federal and state agencies. Governance was adapted to incorporate Model N Medicaid approval gates and validation-driven exception handling into existing rebate processes, and the system delivered outcomes that included reduced analyst workload, increased payment accuracy and improved audit-readiness for government filings as reported.
Novo Nordisk US Life Sciences 7257 $1.8B United States Model N Model N Medicaid Governance, Risk and Compliance 2006 n/a
In 2006 Novo Nordisk Inc. implemented Model N Medicaid Claims Processing, deploying Model N Medicaid within its Governance, Risk and Compliance tooling to automate Medicaid rebate administration in the United States. The implementation targeted finance and government pricing and compliance functions, establishing a centralized system to manage Medicaid and state supplemental claims across U.S. operations. The Model N Medicaid Claims Processing deployment focused on claims ingestion, validation, rebate calculation and regulatory reporting capabilities. Configuration emphasized automated validation rules, structured rebate calculation workflows and standardized reporting outputs to support finance and compliance use cases, with Model N Medicaid used as the authoritative system for Medicaid rebate computations and claim lifecycle orchestration. Governance and process changes accompanied the rollout, aligning finance, government pricing and compliance workflows to the new application and formalizing timing and validation checkpoints for rebate submissions. The implementation improved validation and timely reporting of rebate claims, enabling more accurate Medicaid rebate calculations and stronger regulatory compliance.
Salix Pharmaceuticals Life Sciences 7100 $1.9B United States Model N Model N Medicaid Governance, Risk and Compliance 2007 n/a
In 2007, Salix Pharmaceuticals implemented Model N Medicaid as part of a broader adoption of the Model N Revenue Management suite. The implementation targeted Governance, Risk and Compliance functions to centralize government pricing calculations and statutory reporting for the United States market. Configuration emphasized the Model N Medicaid application for Medicaid and Average Manufacturer Price AMP reporting, alongside revenue management capabilities to automate government pricing calculations. Functional modules included Medicaid and AMP reporting workflows, pricing data consolidation, and rules-based calculation engines aligned with government pricing compliance. These modules replaced manual spreadsheet processes and introduced automated calculation and reporting pipelines. Operational coverage focused on the finance and government pricing compliance organization at Salix Pharmaceuticals in the United States. The deployment supported regular regulatory reporting cycles and the adoption of regulatory updates, with Model N Medicaid instrumented into existing reporting workflows to produce statutory outputs. Integrations are described at the workflow level, with operational handoffs between pricing calculation modules and statutory reporting processes rather than named external systems. Governance and process restructuring standardized compliance workflows and reduced manual touchpoints, outcomes that included faster regulatory update adoption and lower analyst burden as stated. Model N Medicaid served as the core compliance ledger within the Model N Revenue Management suite for Medicaid pricing and AMP reporting at Salix Pharmaceuticals.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Model N Medicaid

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Model N Medicaid. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Model N Medicaid Coverage

Model N Medicaid is a Governance, Risk and Compliance solution from Model N.

Companies worldwide use Model N Medicaid, from small firms to large enterprises across 21+ industries.

Organizations such as Janssen United States, Salix Pharmaceuticals and Novo Nordisk US are recorded users of Model N Medicaid for Governance, Risk and Compliance.

Companies using Model N Medicaid are most concentrated in Life Sciences, with adoption spanning over 21 industries.

Companies using Model N Medicaid are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Model N Medicaid across Americas, EMEA, and APAC.

Companies using Model N Medicaid range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 100%, and global enterprises with 10,000+ employees - 0%.

Customers of Model N Medicaid include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Model N Medicaid customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Governance, Risk and Compliance.